2; LEVEL OF EVIDENCE - A]
Apligraf, an allogeneic bilayer cellular therapy, has been
approved by the FDA for treatment of VLUs. The efÔ¨Åcacy
of Apligraf was studied in an RCT of 245 patients with
VLUs treated with standard of care compared with standard
of care plus the application of Apligraf.259,260 VLUs had been
present for at